HALOVA BENEFITS in healing,
re-epithelializing and / or soothing injured, atrophic or irritated vaginal mucosa.

HALOVA is a medical device intended for intravaginal use with the aim of promoting and/or accelerating hydration, healing, re-epithelialization and/or soothing of injured, atrophic or irritated vaginal mucosa. The ovules melt evenly on the vaginal mucosa, forming a cream that contributes to restoring the normal lubrication of the vaginal mucosa and helps to maintain a normal pH and vaginal flora.

Halova is a medical device intended for use in the:

treatment of vaginal dryness caused by age or various pathologies
treatment of vaginal dryness caused by other drug treatments
relief of pain and discomfort during sexual intercourse
balancing of the vaginal flora
treatment of vaginal pH disturbances

The main mechanism of action of the medical device is the dispersion of substances in the vagina and the formation of a protective film for the vaginal mucosa with moisturizing, re-epithelializing properties, normalizing the vaginal pH, which favors the maintenance of normal vaginal flora and which can be used both alone as well as together with hormonal treatment to restore the natural lubrication of the vaginal mucosa.

The recommended dose is 1 ovule administered vaginally, preferably in the evening. Treatment begins on the first day after menstruation.

to prevent the occurrence of vaginal infections due to excessive hygiene or various environmental factors – 10 consecutive days, twice a year
premenopause and menopause – one ovule a day, in the evening for the first 10 days. The action may take 1-2 months after which, depending on the individual estrogen profile, it may be necessary to repeat the therapy
to reduce pain and discomfort during intercourse, associated with vaginal dryness, 1 ovule a day, 10 consecutive days, preferably in the evening
to restore the vaginal pH and balance the vaginal flora, 1 ovule a day, 10 consecutive days, preferably in the evening

Improvement may occur in the first month of treatment. It can be repeated for several months, until it heals or to consolidate and maintain the favourable effects obtained.

The recommended dose is 1 ovule administered vaginally, preferably in the evening. Treatment begins on the first day after menstruation.

to prevent the occurrence of vaginal infections due to excessive hygiene or various environmental factors – 10 consecutive days, twice a year
premenopause and menopause – one ovule a day, in the evening for the first 10 days. The action may take 1-2 months after which, depending on the individual estrogen profile, it may be necessary to repeat the therapy
to reduce pain and discomfort during intercourse, associated with vaginal dryness, 1 ovule a day, 10 consecutive days, preferably in the evening
to restore the vaginal pH and balance the vaginal flora, 1 ovule a day, 10 consecutive days, preferably in the evening

Improvement may occur in the first month of treatment. It can be repeated for several months, until it heals or to consolidate and maintain the favourable effects obtained.

Therapeutic action of the main active ingredients of Halova in the healing, reepithelialization and / or soothing of injured, atrophic or irritated vaginal mucosa.